These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 17062329

  • 1. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
    Haywood WM, Mukaetova-Ladinska EB.
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
    [Abstract] [Full Text] [Related]

  • 2. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB, Keohane DJ, Erwin WG, McRae T, Shah SN.
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [Abstract] [Full Text] [Related]

  • 3. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.
    Am J Geriatr Pharmacother; 2006 Jun; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN.
    J Clin Psychiatry; 2006 Jun; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increasing rational use of cholinesterase inhibitors for Alzheimer's disease in Brazil: public health strategy combining guideline with peer-review of prescriptions.
    Picon PD, Camozzato AL, Lapporte EA, Picon RV, Moser Filho H, Cerveira MO, Chaves ML.
    Int J Technol Assess Health Care; 2010 Apr; 26(2):205-10. PubMed ID: 20392325
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The cognitive effects of cholinesterase inhibitor treatment in every-day practice.
    Kapaki E, Paraskevas GP.
    Curr Med Res Opin; 2005 Jun; 21(6):871-5. PubMed ID: 15969887
    [Abstract] [Full Text] [Related]

  • 13. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M.
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL, Mackell J, Kaufer D.
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA, Ott BR, Lapane KL, Reinert SE, Machan JT, Dore DD.
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [Abstract] [Full Text] [Related]

  • 19. Switching cholinesterase inhibitors in patients with Alzheimer's disease.
    Emre M.
    Int J Clin Pract Suppl; 2002 Jun; (127):64-72. PubMed ID: 12139369
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.